Journal
FEMS YEAST RESEARCH
Volume 15, Issue 6, Pages -Publisher
OXFORD UNIV PRESS
DOI: 10.1093/femsyr/fov066
Keywords
Candida glabrata; virulence; tools; technologies; Candida; S. cerevisiae
Funding
- BBSRC [BB/F005210/2]
- Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology [097377/Z/11/Z]
- Biotechnology and Biological Sciences Research Council [BB/F005210/2] Funding Source: researchfish
- BBSRC [BB/F005210/2] Funding Source: UKRI
Ask authors/readers for more resources
In recent years, there has been a noticeable rise in fungal infections related to non-albicans Candida species, including Candida glabrata which has both intrinsic resistance to and commonly acquired resistance to azole antifungals. Phylogenetically, C. glabrata is more closely related to the mostly non-pathogenic model organism Saccharomyces cerevisiae than to other Candida species. Despite C. glabrata's designation as a pathogen by Wickham in 1957, relatively little is known about its mechanism of virulence. Over the past few years, technology to analyse the molecular basis of infection has developed rapidly, and here we briefly review the major advances in tools and technologies available to explore and investigate the virulence of C. glabrata that have occurred over the past decade.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available